Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Omega Healthcare
OHI
$14.7B
| $12.6M | 0.01% |
298,314
+263,675
| +761% | +$11.2M |
|
|
B
1227
CALL
Barrick Mining
B
$73.2B
| $12.6M | 0.01% |
679,000
-84,348
| -11% | -$1.45M |
|
1228
PUT
Ralph Lauren
RL
$23.6B
| $12.6M | 0.01% |
107,500
+2,300
| +2% | +$242K |
|
1229
Teledyne Technologies
TDY
$32B
| $12.6M | 0.01% |
36,358
+18,603
| +105% | +$6.25M |
|
1230
Veeva Systems
VEEV
$37.4B
| $12.6M | 0.01% |
89,545
-117,244
| -57% | -$17.2M |
|
|
KSU
1231
CALL
DELISTED
Kansas City Southern
KSU
| $12.6M | 0.01% |
82,000
+71,000
| +645% | +$10.4M |
|
1232
Assurant
AIZ
$14.3B
| $12.5M | 0.01% |
95,686
+31,009
| +48% | +$3.99M |
|
1233
PUT
Avis
CAR
$5.02B
| $12.5M | 0.01% |
388,400
+20,100
| +5% | +$603K |
|
|
AMRN
1234
PUT
Amarin Corp
AMRN
$303M
| $12.5M | 0.01% |
29,165
+5,770
| +25% | +$2.19M |
|
1235
Arch Capital
ACGL
$33.6B
| $12.5M | 0.01% |
291,298
+71,405
| +32% | +$2.96M |
|
|
XENT
1236
DELISTED
Intersect ENT, Inc
XENT
| $12.5M | 0.01% |
501,651
+173,833
| +53% | +$3.52M |
|
1237
PUT
Southern Company
SO
$107B
| $12.4M | 0.01% |
195,400
+37,400
| +24% | +$2.32M |
|
1238
West Pharmaceutical
WST
$24.9B
| $12.4M | 0.01% |
82,671
-17,681
| -18% | -$2.57M |
|
1239
CALL
RH
RH
$3.71B
| $12.4M | 0.01% |
58,000
-13,800
| -19% | -$2.69M |
|
1240
Nutrien
NTR
$30.7B
| $12.4M | 0.01% |
258,280
+72,970
| +39% | +$3.53M |
|
1241
CALL
Constellation Brands
STZ
$23.2B
| $12.4M | 0.01% |
65,200
+4,200
| +7% | +$793K |
|
1242
PUT
Check Point Software Technologies
CHKP
$13.1B
| $12.4M | 0.01% |
111,400
+19,900
| +22% | +$2.24M |
|
1243
CALL
Intuitive Surgical
ISRG
$134B
| $12.4M | 0.01% |
62,700
-27,600
| -31% | -$5.17M |
|
1244
PUT
MGM Resorts International
MGM
$11.2B
| $12.3M | 0.01% |
371,100
-9,800
| -3% | -$299K |
|
1245
Genworth Financial
GNW
$3.71B
| $12.3M | 0.01% |
2,801,333
+746,522
| +36% | +$3.14M |
|
|
ONC
1246
BeOne Medicines Ltd
ONC
$39.4B
| $12.3M | 0.01% |
74,352
+10,134
| +16% | +$1.68M |
|
|
ALXN
1247
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $12.3M | 0.01% |
113,900
-60,100
| -35% | -$6.43M |
|
1248
CALL
Eli Lilly
LLY
$1.06T
| $12.3M | 0.01% |
93,600
-41,200
| -31% | -$4.78M |
|
1249
PUT
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.31B
| $12.3M | 0.01% |
112,298
+23,600
| +27% | +$2.56M |
|
|
BLUE
1250
DELISTED
bluebird bio
BLUE
| $12.3M | 0.01% |
10,815
+8,400
| +348% | +$9.13M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.